Healthcare Professionals

Source Control Through Rapid Extracorporeal Blood Filtration of Pathogens

Seraph 100 reduces the blood concentration of SARS-CoV-2, the virus that causes COVID-19. Clinicians have reported improved outcomes, hemodynamic stability, reduction of vasopressors and fractionally inspired oxygen, and avoidance or reduced time of mechanical ventilation.1, 2, 3

Seraph 100 in the Field

Seraph 100 Microbind Affinity Blood Filter Technology

Seraph 100 is being used in hospitals across the United States, including several military hospitals. Several hospitals have presented their findings:

Providers Using Seraph 100

in the United States

Please read our information sheet to learn more about the device and how to order it.

For FDA guidance on the use of Seraph 100 on COVID-19 patients, please follow the links below:


MM0003 Rev A